Task order entitled, "pharmacodynamics of the MAS-related gene X2 (MRGX2) antagonist SYR268215 in the humanized MRGX2 knock-in (KI) mouse."
Ended Awarded Last action
- Contract number
- 75N95020F00001
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,694
Award facts
- Contract value 100% obligated
- $1,694.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albuquerque, NM 87108, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$174,821 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $176,515 |
About this award
This is a task order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The $1,694.39 task order is for a study on the pharmacodynamics of a MAS-related gene X2 (MRGX2) antagonist in a humanized MRGX2 knock-in mouse model. The work falls under an Indefinite Delivery Indefinite Quantity (IDIQ) contract awarded by NCATS for medicinal chemistry and lead optimization research. There is no set-aside designation for this task order. Lovelace Biomedical Research Institute conducts a wide range of preclinical research and development services, including animal studies, for federal agencies such as the National Institutes of Health, Department of Defense, and Department of Health and Human Services.
Quick answers
Who was awarded contract 75N95020F00001?
75N95020F00001 was awarded to Lovelace Biomedical Research Institute by National Institute on Drug Abuse (National Institutes of Health) on September 14, 2020.
How much is contract 75N95020F00001 worth?
The government has obligated $1,694 on 75N95020F00001.
Which agency awarded contract 75N95020F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020F00001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95020F00001 an order under another contract?
Yes. 75N95020F00001 is a delivery order under 75N95019D00012, an indefinite delivery contract.
Was contract 75N95020F00001 competed?
The extent of competition for 75N95020F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award